Search Results - "Poortmans, Philip M. P."

The 2016 Assisi Think Tank Meeting on breast cancer: white paper by Aristei, Cynthia, Kaidar-Person, Orit, Arenas, Meritxell, Coles, Charlotte, Offersen, Birgitte V., Bourgier, Celine, Frezza, Giovanni, Leonardi, Maria Cristina, Valentini, Vincenzo, Poortmans, Philip M. P.

“…Purpose To identify weak points in daily routine use of radiation therapy (RT) for non-metastatic breast cancer patients, particularly when data are lacking or…”
Get full text

Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged ≤40 years by van der Sangen, Maurice J. C., van de Wiel, Fenneke M. M., Poortmans, Philip M. P., Tjan-Heijnen, Vivianne C. G., Nieuwenhuijzen, Grard A. P., Roumen, Rudi M. H., Ernst, Miranda F., Tutein Nolthenius-Puylaert, M. Cathelijne B. J. E., Voogd, Adri C.

“…To compare the effectiveness of breast-conserving therapy (BCT) and mastectomy, all women aged ≤40 years, treated for early-stage breast cancer in the southern…”
Get full text

Breast conserving therapy and mastectomy revisited: Breast cancer‐specific survival and the influence of prognostic factors in 129,692 patients by Lagendijk, Mirelle, van Maaren, Marissa C., Saadatmand, Sepideh, Strobbe, Luc J.A., Poortmans, Philip M.P., Koppert, Linetta B., Tilanus‐Linthorst, Madeleine M.A., Siesling, Sabine

“…This large population‐based study compared breast‐conserving surgery with radiation therapy (BCT) with mastectomy on (long‐term) breast cancer‐specific (BCSS)…”
Get full text

Ten‐year recurrence rates for breast cancer subtypes in the Netherlands: A large population‐based study by Maaren, Marissa C., Munck, Linda, Strobbe, Luc J.A., Sonke, Gabe S., Westenend, Pieter J., Smidt, Marjolein L., Poortmans, Philip M.P., Siesling, Sabine

“…Here we report for the first time the relation between breast cancer subtypes and 10‐year recurrence rates and mortality in the Netherlands. All operated women…”
Get full text

Duration of Androgen Suppression in the Treatment of Prostate Cancer by Bolla, Michel, de Reijke, Theodorus M, Van Tienhoven, Geertjan, Van den Bergh, Alphonsus C.M, Oddens, Jorg, Poortmans, Philip M.P, Gez, Eliahu, Kil, Paul, Akdas, Atif, Soete, Guy, Kariakine, Oleg, van der Steen-Banasik, Elsbietha M, Musat, Elena, Piérart, Marianne, Mauer, Murielle E, Collette, Laurence

“…A current standard treatment for locally advanced prostate cancer is external-beam radiotherapy combined with 3 years of androgen suppression. Adverse events,…”
Get full text

International study on low-grade primary central nervous system lymphoma by Jahnke, Kristoph, Korfel, Agnieszka, O'Neill, Brian Patrick, Blay, Jean-Yves, Abrey, Lauren E., Martus, Peter, Poortmans, Philip M. P., Shenkier, Tamara N., Batchelor, Tracy T., Neuwelt, Edward A., Raizer, Jeffrey J., Schiff, David, Pels, Hendrik, Herrlinger, Ulrich, Stein, Harald, Thiel, Eckhard

“…Objective The aim of this study was to characterize the clinical presentation, course, and outcome of low‐grade primary central nervous system lymphoma…”
Get full text

Increased risk for second primary rectal cancer after pelvic radiation therapy by Rombouts, Anouk J.M., Hugen, Niek, Elferink, Marloes A.G., Poortmans, Philip M.P., Nagtegaal, Iris D., de Wilt, Johannes H.W.

“…The aim of this study was to analyse the association between pelvic radiation therapy (RT) and the development of rectal cancer as a second primary cancer…”
Get full text

Ten-year conditional recurrence risks and overall and relative survival for breast cancer patients in the Netherlands: Taking account of event-free years by van Maaren, Marissa C., Strobbe, Luc J.A., Smidt, Marjolein L., Moossdorff, Martine, Poortmans, Philip M.P., Siesling, Sabine

“…Survival estimates from diagnosis are of limited importance for (ex-)breast cancer patients who survived several years, as it includes information on already…”
Get full text

Treatment of Regional Lymph Nodes in Breast Cancer-Evidence in Favor of Radiation Therapy by Poortmans, Philip M P, Coles, Charlotte, Bernier, Jacques

Get more information

Unanswered Questions Concerning Locoregional Irradiation in Breast Cancer-Reply by Poortmans, Philip M P, Coles, Charlotte, Bernier, Jacques

Get more information

Over-irradiation by Poortmans, Philip M.P, Arenas, Meritxell, Livi, Lorenzo

“…Abstract Decreasing the burden of radiation therapy (RT) for breast cancer includes, next to complete omission, several ways to tailor the extent of RT…”
Get full text

De-escalation of radiotherapy after primary chemotherapy in cT1–2N1 breast cancer (RAPCHEM; BOOG 2010–03): 5-year follow-up results of a Dutch, prospective, registry study by de Wild, Sabine R, de Munck, Linda, Simons, Janine M, Verloop, Janneke, van Dalen, Thijs, Elkhuizen, Paula H M, Houben, Ruud M A, van Leeuwen, A Elise, Linn, Sabine C, Pijnappel, Ruud M, Poortmans, Philip M P, Strobbe, Luc J A, Wesseling, Jelle, Voogd, Adri C, Boersma, Liesbeth J

“…Primary chemotherapy in breast cancer poses a dilemma with regard to adjuvant locoregional radiotherapy, as guidelines for locoregional radiotherapy were…”
Get full text

Short Androgen Suppression and Radiation Dose Escalation for Intermediate- and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991 by Bolla, Michel, Maingon, Philippe, Carrie, Christian, Villa, Salvador, Kitsios, Petros, Poortmans, Philip M P, Sundar, Santhanam, van der Steen-Banasik, Elzbieta M, Armstrong, John, Bosset, Jean-François, Herrera, Fernanda G, Pieters, Bradley, Slot, Annerie, Bahl, Amit, Ben-Yosef, Rahamim, Boehmer, Dirk, Scrase, Christopher, Renard, Laurette, Shash, Emad, Coens, Corneel, van den Bergh, Alphonsus C M, Collette, Laurence

“…Up to 30% of patients who undergo radiation for intermediate- or high-risk localized prostate cancer relapse biochemically within 5 years. We assessed if…”
Get full text

Exclusive endocrine therapy or partial breast irradiation for women aged ≥70  years with luminal A-like early stage breast cancer (NCT04134598 – EUROPA): Proof of concept of a randomized controlled trial comparing health related quality of life by patient reported outcome measures by Meattini, Icro, Poortmans, Philip M.P., Marrazzo, Livia, Desideri, Isacco, Brain, Etienne, Hamaker, Marije, Lambertini, Matteo, Miccinesi, Guido, Russell, Nicola, Saieva, Calogero, Strnad, Vratislav, Visani, Luca, Kaidar-Person, Orit, Livi, Lorenzo

“…Postoperative radiation therapy after breast conserving surgery in the older adult population is a matter of debate; although radiation therapy was shown to…”
Get full text

Patient Positioning Based on a Radioactive Tracer Implanted in Patients With Localized Prostate Cancer: A Performance and Safety Evaluation by de Kruijf, Willy J.M., PhD, Verstraete, Jan, Neustadter, David, PhD, Corn, Benjamin W., MD, Hol, Sandra, Venselaar, Jack L.M., PhD, Davits, Rob J., MD, Wijsman, Bart P., MD, Van den Bergh, Laura, MD, Budiharto, Tom, MD, Oyen, Raymond, PhD, Haustermans, Karin, PhD, Poortmans, Philip M.P., PhD

“…Purpose To evaluate the performance and safety of a radiation therapy positioning system (RealEye) based on tracking a radioactive marker (Tracer) implanted in…”
Get full text

Effectiveness of low-dose radiation therapy on symptoms in patients with knee osteoarthritis: a randomised, double-blinded, sham-controlled trial by Mahler, Elien A M, Minten, Michiel Jm, Leseman-Hoogenboom, Mathilde M, Poortmans, Philip M P, Leer, Jan Willem H, Boks, Simone S, van den Hoogen, Frank H J, den Broeder, Alfons A, van den Ende, Cornelia H M

“…Low-dose radiation therapy (LDRT) for benign disorders such as knee osteoarthritis (OA) is widely used in some parts of the world, despite absence of…”
Get more information

Is Postoperative Breast Radiation Therapy Safe in Patients With Scleroderma? by Belkacemi, Yazid, Majdoul, Soufya, Tsoutsou, Pelagia Pauletta, Abouegylah, Mohamed, Kaidar-Person, Orit, Meattini, Icro, Poortmans, Philip M.P., Taghian, Alphonse

Get full text

Winter is over: The use of Artificial Intelligence to individualise radiation therapy for breast cancer by Poortmans, Philip M.P., Takanen, Silvia, Marta, Gustavo Nader, Meattini, Icro, Kaidar-Person, Orit

“…Artificial intelligence demonstrated its value for automated contouring of organs at risk and target volumes as well as for auto-planning of radiation dose…”
Get full text

Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma by Schaapveld, Michael, Aleman, Berthe M.P, van Eggermond, Anna M, Janus, Cécile P.M, Krol, Augustinus D.G, van der Maazen, Richard W.M, Roesink, Judith, Raemaekers, John M.M, de Boer, Jan Paul, Zijlstra, Josée M, van Imhoff, Gustaaf W, Petersen, Eefke J, Poortmans, Philip M.P, Beijert, Max, Lybeert, Marnix L, Mulder, Ina, Visser, Otto, Louwman, Marieke W.J, Krul, Inge M, Lugtenburg, Pieternella J, van Leeuwen, Flora E

“…Despite efforts to reduce the incidence of second cancer, the risk was not lower among 5-year survivors of Hodgkin's lymphoma in the Netherlands treated…”
Get full text

Surgery and radiation therapy of triple-negative breast cancers: From biology to clinics by Bernier, Jacques, Poortmans, Philip M.P

“…Abstract Triple negative breast cancer refers to tumours lacking the expression of the three most used tumour markers, namely oestrogen receptors, progesterone…”
Get full text